Annuloplasty System Market Report Provides Insights Into Market Evolution And Growth Prospects

The annuloplasty system market is on track for significant expansion over the next decade, driven by advances in cardiac care and evolving treatment methods. With improvements in minimally invasive procedures and an aging population facing valve disorders, this sector is poised for remarkable growth. Let's explore the market's size, influential players, emerging trends, and the segmentation that defines this specialized industry.

Projected Market Growth of the Annuloplasty System Market Until 2030
The annuloplasty system market is expected to experience solid growth, reaching a valuation of $0.97 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 6.8%. Key factors contributing to this growth include the rising demand for minimally invasive cardiac surgeries, the increasing number of elderly patients with valve conditions, the growing use of robotic cardiac surgery, broader availability of transcatheter treatment options, and ongoing innovations in device design. Noteworthy trends during this period involve the adoption of minimally invasive valve repair methods, the expansion of robotic-assisted annuloplasty procedures, preference for flexible and adjustable devices, growth in transcatheter annuloplasty systems, and an intensified focus on improving long-term valve durability.

Download a free sample of the annuloplasty system market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24143&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Players Leading the Annuloplasty System Market
Several influential companies shape the landscape of the annuloplasty system market, including Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, Terumo Corporation, B. Braun Melsungen AG, B. Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A., Cardiac Implants LLC, Medtentia International Ltd., and Corcym S.r.l.

Significant Acquisition Enhancing Market Presence
In July 2024, France-based medical device firm Affluent Medical SAS acquired Edwards Lifesciences Corporation for $16.3 million. This strategic move aims to boost Affluent Medical's position in the cardiovascular sector by expanding its heart valve solutions portfolio. The acquisition supports the company's goal to accelerate innovative treatments for heart disease and improve patient outcomes. Edwards Lifesciences, headquartered in the US, specializes in annuloplasty systems designed for mitral and tricuspid valve repair, aiding in the restoration of heart valve function.

View the full annuloplasty system market report:
https://www.thebusinessresearchcompany.com/report/annuloplasty-system-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Innovations Driving the Annuloplasty System Market Forward
Leading companies within the annuloplasty system market are prioritizing the development of next-generation surgical valves and devices to improve efficiency during procedures and enhance long-term patient results. These advanced devices are designed to simplify implantation, reduce the complexity of surgery, and enhance the precision and durability of valve repairs or replacements. For example, in June 2024, Medtronic plc launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve. This innovative product features a low-profile valve holder and a durable ket*one (PEEK) base frame, which ease surgical implantation and improve performance over time. It also promotes better blood flow and offers clear visibility for future valve-in-valve interventions.

Detailed Segmentation of the Annuloplasty System Market
The annuloplasty system market is categorized into several major segments:
1) By Device Type: Annular Rings and Bands, Suture Annuloplasty Devices
2) By Procedure Type: Open Heart Surgery, Minimally Invasive Annuloplasty, Robotic Assisted Annuloplasty
3) By Valve Type: Mitral Valve, Tricuspid Valve, Aortic Valve, Pulmonary Valve
4) By End User: Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers

Subdivisions within these categories include:
- Annular Rings and Bands: Rigid Annuloplasty Rings, Semi-Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Complete Annuloplasty Rings, Incomplete Annuloplasty Rings
- Suture Annuloplasty Devices: Adjustable Suture Annuloplasty Devices, Non-Adjustable Suture Annuloplasty Devices, Transcatheter Suture Annuloplasty Systems, Robotic-Assisted Suture Annuloplasty Devices

This comprehensive classification helps illustrate the diverse range of products and procedures that define the annuloplasty system market today.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.